Clinical TrialsSearch results
Number of results: 321
Recruiting
- Utility of Antigen Detecting Tests of Serum and BALF in Diagnosing Respiratory Infectious Diseases
- Respiratory Infectious Diseases
- Nagasaki University Graduate School of Biomedical Sciences
- 2009-11-09
Other
- Detection of abnormal sound by digitization of respiratory sounds
- respiratory diseases
- Toshi Eria Kiagi
- 2009-04-01
Other
- clinical trial of CHP-HER2 cancer vaccine with immuno-adjuvant, OK-432, for advanced breast cancer
- Resected locally-advanced breast cancer
- Mie University, University of Ocupational and Environmental Health, Nagasaki University, National Hospital Organization Saga National Hospital, Hamamatsu Medical Center
- 2008-08-02
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
No Longer Recruiting
- A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies
- Relapsed/Refractory AML, Minimal Residual Disease Positive AML, Myelodysplastic Syndrome
- Contact Local
- 2021-07-19
Recruiting
- Phase 3 Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (SUCCESSOR-1)
- Relapsed or Refractory Multiple Myeloma (RRMM)
- Nishio Mitsufumi
- 2023-12-04
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Other
- Randomised controlled trial of multiple drugs combined therapy for diffuse IgA nephropathy
- Refractory IgA nephropathy
- Japanese Study Group of Multiple drug therapy for IgAN
- 2006-03-31